Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP2A13 | Q16696 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | DBH | P09172 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248417 | 0.82 | IDO1 (0.50) | PNMTTAAR1IDO1GABRA1GABRB2 | |
| SCHEMBL29473927 | 0.82 | IDO1 (0.50) | PNMTTAAR1IDO1GABRA1GABRB2 | |
| Hydrochloric Acid SCHEMBL11666235 | 0.80 | IDO1 (0.48) | PNMTTAAR1IDO1GABRA1GABRB2 | |
| SCHEMBL9275883 | 0.80 | IDO1 (0.48) | PNMTTAAR1IDO1GABRA1GABRB2 | |
| SCHEMBL7499710 | 0.79 | GABRA1 (0.46) | PNMTTAAR1IDO1GABRA1GABRB2 | |
| SCHEMBL7499705 | 0.79 | GABRA1 (0.46) | PNMTTAAR1IDO1GABRA1GABRB2 | |
| SCHEMBL1908482 | 0.79 | GABRA1 (0.66) | GABRA1GABRB2ALDH1A1KDM4EHPGD | |
| SCHEMBL7696946 | 0.79 | GABRA1 (0.46) | PNMTGABRA1GABRB2ALDH1A1KDM4E | |
| SCHEMBL2364383 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2ALDH1A1KDM4EPOLB | |
| SCHEMBL7499718 | 0.79 | GABRA1 (0.46) | PNMTTAAR1IDO1GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3951614-A | REACTION PRODUCT OF A HYDROCARBYL AMINE AND POLYFUNCTIONAL COUPLING AGENT | CHEVRON RESEARCH COMPANY (US) | 1976-04-20 | — | — | US | claimed |
| EP-3527593-B1 | ISOCYANATE COMPOSITION, METHOD FOR PRODUCING ISOCYANATE COMPOSITION, AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-23 | — | — | EP | disclosed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-112979917-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-109790269-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| EP-3536683-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2021-11-24 | — | — | EP | disclosed |
| CN-107963982-B | Polyisocyanate composition and isocyanate polymer composition | 旭化成株式会社 | 2021-11-12 | — | — | CN | disclosed |
| WO-2013100567-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN AND NEUROPATHIC PAIN | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013100570-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013100566-A1 | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013100569-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING MULTIPLE SCLEROSIS | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-07-04 | — | — | WO | disclosed |
| EP-2590936-A2 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | Bio-Pharm Solutions Co., Ltd. (KR) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012096458-A2 | PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2012-07-19 | — | — | WO | disclosed |
| WO-2012002773-A2 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2012-01-05 | — | — | WO | disclosed |
| US-5030777-A | Synthesis of 3,5-dichloroalkylbenzene and recovery of 1,3-dichlorobenzene | STANDARD CHLORINE OF DELAWARE, INC. (US) | 1991-07-09 | — | — | US | disclosed |
| EP-0115985-B1 | PROCESS FOR THE ALKYLATION OF HALOGENATED AND/OR TRIFLUORMETHYLATED BENZENEDERIVATIVES | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1985-12-18 | — | — | EP | disclosed |
| EP-0115985-A1 | Process for the alkylation of halogenated and/or trifluormethylated benzenederivatives | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | PNMT 2353/4885TAAR1 4327/4885IDO1 65/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | PNMT 2212/4885TAAR1 4155/4885IDO1 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.